Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk.
Campa D, Pastore M, Gentiluomo M, Talar-Wojnarowska R, Kupcinskas J, Malecka-Panas E, Neoptolemos JP, Niesen W, Vodicka P, Delle Fave G, Bueno-de-Mesquita HB, Gazouli M, Pacetti P, Di Leo M, Ito H, Klüter H, Soucek P, Corbo V, Yamao K, Hosono S, Kaaks R, Vashist Y, Gioffreda D, Strobel O, Shimizu Y, Dijk F, Andriulli A, Ivanauskas A, Bugert P, Tavano F, Vodickova L, Zambon CF, Lovecek M, Landi S, Key TJ, Boggi U, Pezzilli R, Jamroziak K, Mohelnikova-Duchonova B, Mambrini A, Bambi F, Busch O, Pazienza V, Valente R, Theodoropoulos GE, Hackert T, Capurso G, Cavestro GM, Pasquali C, Basso D, Sperti C, Matsuo K, Büchler M, Khaw KT, Izbicki J, Costello E, Katzke V, Michalski C, Stepien A, Rizzato C, Canzian F. Campa D, et al. Among authors: gentiluomo m. Oncotarget. 2016 Aug 30;7(35):57011-57020. doi: 10.18632/oncotarget.10935. Oncotarget. 2016. PMID: 27486979 Free PMC article.
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors.
Campa D, Capurso G, Pastore M, Talar-Wojnarowska R, Milanetto AC, Landoni L, Maiello E, Lawlor RT, Malecka-Panas E, Funel N, Gazouli M, De Bonis A, Klüter H, Rinzivillo M, Delle Fave G, Hackert T, Landi S, Bugert P, Bambi F, Archibugi L, Scarpa A, Katzke V, Dervenis C, Liço V, Furlanello S, Strobel O, Tavano F, Basso D, Kaaks R, Pasquali C, Gentiluomo M, Rizzato C, Canzian F. Campa D, et al. Among authors: gentiluomo m. Sci Rep. 2016 Dec 23;6:39565. doi: 10.1038/srep39565. Sci Rep. 2016. PMID: 28008994 Free PMC article.
Taste receptor polymorphisms and male infertility.
Gentiluomo M, Crifasi L, Luddi A, Locci D, Barale R, Piomboni P, Campa D. Gentiluomo M, et al. Hum Reprod. 2017 Nov 1;32(11):2324-2331. doi: 10.1093/humrep/dex305. Hum Reprod. 2017. PMID: 29040583
Genetic variability of the ABCC2 gene and clinical outcomes in pancreatic cancer patients.
Gentiluomo M, Puchalt García P, Galeotti AA, Talar-Wojnarowska R, Tjaden C, Tavano F, Strobel O, Kupcinskas J, Neoptolemos J, Hegyi P, Costello E, Pezzilli R, Sperti C, Lawlor RT, Capurso G, Szentesi A, Soucek P, Vodicka P, Lovecek M, Hackert T, Cavestro GM, Milanetto AC, Canzian F, Campa D. Gentiluomo M, et al. Carcinogenesis. 2019 Jun 10;40(4):544-550. doi: 10.1093/carcin/bgz006. Carcinogenesis. 2019. PMID: 30629142
Mitochondrial DNA Copy-Number Variation and Pancreatic Cancer Risk in the Prospective EPIC Cohort.
Gentiluomo M, Katzke VA, Kaaks R, Tjønneland A, Severi G, Perduca V, Boutron-Ruault MC, Weiderpass E, Ferrari P, Johnson T, Schulze MB, Bergmann M, Trichopoulou A, Karakatsani A, La Vecchia C, Palli D, Grioni S, Panico S, Tumino R, Sacerdote C, Bueno-de-Mesquita B, Vermeulen R, Sandanger TM, Quirós JR, Rodriguez-Barranco M, Amiano P, Colorado-Yohar S, Ardanaz E, Sund M, Khaw KT, Wareham NJ, Schmidt JA, Jakszyn P, Morelli L, Canzian F, Campa D. Gentiluomo M, et al. Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):681-686. doi: 10.1158/1055-9965.EPI-19-0868. Epub 2020 Jan 13. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 31932413 Free PMC article.
Genome-wide association study identifies an early onset pancreatic cancer risk locus.
Campa D, Gentiluomo M, Obazee O, Ballerini A, Vodickova L, Hegyi P, Soucek P, Brenner H, Milanetto AC, Landi S, Gao X, Bozzato D, Capurso G, Tavano F, Vashist Y, Hackert T, Bambi F, Bursi S, Oliverius M, Gioffreda D, Schöttker B, Ivanauskas A, Mohelnikova-Duchonova B, Darvasi E, Pezzilli R, Małecka-Panas E, Strobel O, Gazouli M, Katzke V, Szentesi A, Cavestro GM, Farkas G Jr, Izbicki JR, Moz S, Archibugi L, Hlavac V, Vincze Á, Talar-Wojnarowska R, Rusev B, Kupcinskas J, Greenhalf B, Dijk F, Giese N, Boggi U, Andriulli A, Busch OR, Vanella G, Vodicka P, Nentwich M, Lawlor RT, Theodoropoulos GE, Jamroziak K, Zuppardo RA, Moletta L, Ginocchi L, Kaaks R, Neoptolemos JP, Lucchesi M, Canzian F. Campa D, et al. Among authors: gentiluomo m. Int J Cancer. 2020 Oct 15;147(8):2065-2074. doi: 10.1002/ijc.33004. Epub 2020 May 1. Int J Cancer. 2020. PMID: 32270874
Role of OPRM1, clinical and anthropometric variants in neonatal pain reduction.
Erbi I, Ciantelli M, Farinella R, Tuoni C, Gentiluomo M, Moscuzza F, Rizzato C, Bedini A, Faraoni M, Giusfredi S, Tavanti A, Ghirri P, Campa D. Erbi I, et al. Among authors: gentiluomo m. Sci Rep. 2020 Apr 27;10(1):7091. doi: 10.1038/s41598-020-63790-2. Sci Rep. 2020. PMID: 32341423 Free PMC article. Clinical Trial.
49 results